Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Aug;87(15):5950-4.
doi: 10.1073/pnas.87.15.5950.

Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors

D M Schmatz  1 , M A Romancheck, L A Pittarelli, R E Schwartz, R A Fromtling, K H Nollstadt, F L Vanmiddlesworth, K E Wilson, M J Turner
Affiliations

Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors

D M Schmatz et al. Proc Natl Acad Sci U S A. 1990 Aug.

Abstract

Pneumocystis carinii pneumonia is a major cause of death in AIDS patients in the United States. The presently available treatments have limited use due to a high incidence of adverse reactions. Therefore, there is an urgent need for a safer method for treatment and prevention of this disease. Recent evidence has suggested that P. carinii is related to fungi and that the wall of the cyst form contains 1,3-beta-glucan as a major constituent. Based on this, several proposed 1,3-beta-glucan synthesis inhibitors were evaluated for their ability to control P. carinii pneumonia in vivo. Compounds from two classes of 1,3-beta-glucan synthesis inhibitors, the echinocandins and papulacandins, were found to be effective against P. carinii.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6503-7 - PubMed
    1. Exp Parasitol. 1989 May;68(4):450-61 - PubMed
    1. Antimicrob Agents Chemother. 1990 Feb;34(2):225-8 - PubMed
    1. J Clin Pathol. 1963 Jul;16:383-4 - PubMed
    1. Lab Invest. 1966 Oct;15(10):1559-77 - PubMed

Publication types

MeSH terms